Interpersonal Psychotherapy for Treatment Resistant Depression
NCT ID: NCT01896349
Last Updated: 2013-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
74 participants
INTERVENTIONAL
2013-04-30
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interpersonal Psychotherapy for Severely Depressed Inpatients
NCT00325000
Fluoxetine vs. Brief Psychotherapy for Major Depression
NCT00714779
Cognitive and Drug Therapy for Drug-Resistant Depression
NCT00000376
Cognitive Therapy for Recurrent Depression
NCT00118404
Treatment Resistant Depression (Pilot)
NCT01179009
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IPT+antidepressant drugs
Interpersonal Psychotherapy protocol (IPT) consist of 16 sessions of manualized interpersonal psychotherapy for depression. Patients are allowed to reschedule 3 sessions if they miss their appointments.
Antidepressant Drugs protocol consist of pharmacological management of depression, oriented by international guidelines, clinician´s free choice. Monotherapy or combinations are allowed. Antidepressant and drugs are: fluoxetine, sertraline, paroxetin, citalopram, escitalopram, fluvoxamine, venlafaxin, duloxetin, bupropion, lithium, risperidone, tranylcypromine, Imipramine, amitriptyline, clomipramine, nortriptyline, trazodone, mirtazapine, sulpiride.
IPT+ antidepressant drugs
16 sessions of interpersonal psychotherapy plus antidepressant drugs.
fluoxetine
Antidepressant drugs, clinician´s free choice oriented by guidelines. Monotherapy or combinations are allowed
sertraline
paroxetine
Citalopram
escitalopram
fluvoxamine
Venlafaxine
Duloxetine
Bupropion
Lithium
Risperidone
tranylcypromine
Imipramine
amitriptyline
Clomipramine
nortriptyline
trazodone
Mirtazapine
sulpiride
Antidepressant Drugs
Drugs protocol consist of pharmacological management of depression, oriented by international guidelines, clinician´s free choice.
Antidepressant Drugs protocol consist of pharmacological management of depression, oriented by international guidelines, clinician´s free choice. Monotherapy or combinations are allowed. Antidepressant and drugs are: fluoxetine, sertraline, paroxetine, citalopram, escitalopram, fluvoxamine, venlafaxine, duloxetine, bupropion, lithium, risperidone, tranylcypromine, Imipramine, amitriptyline, clomipramine, nortriptyline, trazodone, mirtazapine, sulpiride.
fluoxetine
Antidepressant drugs, clinician´s free choice oriented by guidelines. Monotherapy or combinations are allowed
sertraline
paroxetine
Citalopram
escitalopram
fluvoxamine
Venlafaxine
Duloxetine
Bupropion
Lithium
Risperidone
tranylcypromine
Imipramine
amitriptyline
Clomipramine
nortriptyline
trazodone
Mirtazapine
sulpiride
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IPT+ antidepressant drugs
16 sessions of interpersonal psychotherapy plus antidepressant drugs.
fluoxetine
Antidepressant drugs, clinician´s free choice oriented by guidelines. Monotherapy or combinations are allowed
sertraline
paroxetine
Citalopram
escitalopram
fluvoxamine
Venlafaxine
Duloxetine
Bupropion
Lithium
Risperidone
tranylcypromine
Imipramine
amitriptyline
Clomipramine
nortriptyline
trazodone
Mirtazapine
sulpiride
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Currently in or having received psychotherapy in the last 4 weeks
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital de Clinicas de Porto Alegre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcelo PA Fleck, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Federal University of Rio Grande do Sul / Hospital de Clínicas de Porto Alegre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal University of Rio Grande do Sul / Hospital de Clínicas de Porto Alegre (HCPA)
Porto Alegre, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Souza LH, Salum GA, Mosqueiro BP, Caldieraro MA, Guerra TA, Fleck MP. Interpersonal psychotherapy as add-on for treatment-resistant depression: A pragmatic randomized controlled trial. J Affect Disord. 2016 Mar 15;193:373-80. doi: 10.1016/j.jad.2016.01.004. Epub 2016 Jan 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TIP-120288
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.